JPMorgan Downgrades Savient Pharmaceuticals (SVNT) to Neutral
Tweet
Share
E-mailGet Alerts SVNT Hot Sheet
Price: $40.05 --0%
Rating Summary:
2 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
2 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
JPMorgan downgraded Savient Pharmaceuticals (NASDAQ: SVNT) from Overweight to Neutral. PT lowered from $14 to $10.
For more ratings news on Savient Pharmaceuticals click here and for the rating history of Savient Pharmaceuticals click here.
Shares of Savient Pharmaceuticals closed at $8.57 yesterday.
For more ratings news on Savient Pharmaceuticals click here and for the rating history of Savient Pharmaceuticals click here.
Shares of Savient Pharmaceuticals closed at $8.57 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Double Downgrades Mosaic (MOS) to Sell
- Cantor Fitzgerald Downgrades Better Home & Finance Holding (BETR) to Neutral
- Deutsche Bank Downgrades Qifu Technology (3660:HK) (QFIN) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
